Back to GetFilings.com



Table of Contents

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 


 

FORM 10-Q

 


 

x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended June 27, 2004

 

or

 

¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from              to             

 

Commission file number 0-5260

 


 

REMEDYTEMP, INC.

(Exact Name of Registrant as Specified in Its Charter)

 


 

California   95-2890471

(State or Other Jurisdiction of

Incorporation or Organization)

 

(I.R.S. Employer

Identification No.)

 

101 Enterprise

Aliso Viejo, California

  92656
(Address of Principal Executive Offices)   (Zip Code)

 

Registrant’s Telephone Number, Including Area Code: (949) 425-7600

 


 

Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes   x    No  ¨

 

Indicate by check mark whether the Registrant is an accelerated filer (as defined in Rule 12b-2 of the Exchange Act).    Yes  ¨    No  x

 

As of August 5, 2004 there were 8,768,871 of Class A Common Stock and 800,312 shares of Class B Common Stock outstanding.

 



Table of Contents

 

INDEX

 

             Page No.

PART I—FINANCIAL INFORMATION

   
    Item 1.    Financial Statements    
         Consolidated Balance Sheets as of June 27, 2004 (unaudited) and September 28, 2003   3
         Consolidated Statements of Operations for the three and nine fiscal months ended June 27, 2004 and June 29, 2003 (unaudited)   4
         Consolidated Statements of Cash Flows for the nine fiscal months ended June 27, 2004 and June 29, 2003 (unaudited)   5
         Condensed Notes to Consolidated Financial Statements (unaudited)   6
    Item 2.    Management’s Discussion and Analysis of Financial Condition and Results of Operations   15
    Item 3.    Quantitative and Qualitative Disclosures About Market Risk   28
    Item 4.    Controls and Procedures   28

PART II—OTHER INFORMATION

   
    Item 1.    Legal Proceedings   29
    Item 2.    Changes in Securities, Use of Proceeds and Issuer Purchases of Equity Securities   *
    Item 3.    Defaults Upon Senior Securities   *
    Item 4.    Submission of Matters to a Vote of Security Holders   *
    Item 5.    Other Information   *
    Item 6.    Exhibits and Reports on Form 8-K   31

SIGNATURES

  33

* No information provided due to inapplicability of item.


Table of Contents

Remedy Temp, Inc.

 

PART I—FINANCIAL INFORMATION

 

ITEM 1. FINANCIAL STATEMENTS

 

CONSOLIDATED BALANCE SHEETS

(amounts in thousands, except per share amounts)

 

 

    

(unaudited)

June 27,
2004


   

September 28,
2003


 
      
ASSETS                 

Current assets:

                

Cash and cash equivalents

   $ 5,064     $ 13,236  

Investments

     4,820       15,730  

Restricted investments

     3,123       2,654  

Accounts receivable, net of allowance for doubtful accounts of $2,639 and $2,627, respectively

     54,983       60,594  

Prepaid expenses and other current assets

     8,557       6,679  

Deferred and current income taxes

     643       330  
    


 


Total current assets

     77,190       99,223  

Fixed assets, net

     9,780       12,337  

Restricted cash and investments

     37,931       21,615  

Other assets

     394       1,334  

Intangible assets, net of accumulated amortization of $563 and $219, respectively

     2,411       1,655  

Goodwill

     3,403       3,030  
    


 


Total Assets

   $ 131,109     $ 139,194  
    


 


LIABILITIES AND SHAREHOLDERS’ EQUITY                 

Current liabilities:

                

Accounts payable

   $ 1,761     $ 4,790  

Accrued workers’ compensation, current portion (Note 10)

     17,509       15,263  

Accrued payroll, benefits and related costs

     16,338       17,530  

Accrued licensees’ share of gross profit

     2,138       2,231  

Other accrued expenses

     3,611       3,335  
    


 


Total current liabilities

     41,357       43,149  

Accrued workers’ compensation, non-current portion (Note 10)

     22,681       20,681  
    


 


Total liabilities

     64,038       63,830  

Commitments and contingent liabilities (Note 2)

                

Shareholders’ equity:

                

Preferred Stock, $0.01 par value; authorized 5,000 shares; none outstanding

     —         —    

Class A Common Stock, $0.01 par value; authorized 50,000 shares; 8,769 shares issued and outstanding at June 27, 2004 and September 28, 2003

     88       88  

Class B Non-Voting Common Stock, $0.01 par value; authorized 4,530 shares; 800 and 894 shares issued and outstanding at June 27, 2004 and September 28, 2003, respectively

     8       9  

Additional paid-in capital

     41,450       42,674  

Unearned compensation

     (4,076 )     (6,031 )

Accumulated other comprehensive (loss) income

     (240 )     134  

Retained earnings

     29,841       38,490  
    


 


Total shareholders’ equity

     67,071       75,364  
    


 


Total Liabilities and Shareholders’ Equity

   $ 131,109     $ 139,194  
    


 


 

See accompanying notes to consolidated financial statements.

 

3


Table of Contents

Remedy Temp, Inc.

 

CONSOLIDATED STATEMENTS OF OPERATIONS

(amounts in thousands, except per share amounts)

 

(unaudited)

 

     Three Months Ended

    Nine Months Ended

 
     June 27,
2004


    June 29,
2003


    June 27,
2004


   

June 29,

2003


 

Company-owned office revenues

   $ 85,537     $ 74,135     $ 243,153     $ 217,703  

Licensed franchise revenues

     43,378       44,361       126,367       136,494  

Franchise royalties

     335       337       1,110       1,253  

Initial franchise fees

     —         5       16       17  
    


 


 


 


Total revenues

     129,250       118,838       370,646       355,467  

Cost of Company-owned office revenues

     70,867       62,122       206,014       184,680  

Cost of licensed franchise revenues

     34,605       35,279       101,092       108,771  

Licensees’ share of gross profit

     5,900       6,002       17,044       18,363  

Selling and administrative expenses

     18,115       16,327       51,191       47,841  

Depreciation and amortization

     1,253       1,547       4,515       4,052  
    


 


 


 


Loss from operations

     (1,490 )     (2,439 )     (9,210 )     (8,240 )

Other income (expense):

                                

Interest expense

     (102 )     (97 )     (308 )     (294 )

Interest income

     244       232       781       831  

Other, net

     146       158       521       532  
    


 


 


 


Loss before income taxes

     (1,202 )     (2,146 )     (8,216 )     (7,171 )

Provision for (benefit from) income taxes

     106       (1,711 )     433       (4,374 )
    


 


 


 


Loss before cumulative effect of adoption of a new accounting standard

     (1,308 )     (435 )     (8,649 )     (2,797 )

Cumulative effect of adoption of a new accounting standard, net of income taxes of $1,634

     —         —         —         (2,421 )
    


 


 


 


Net loss

   $ (1,308 )   $ (435 )   $ (8,649 )   $ (5,218 )
    


 


 


 


Earnings per share – basic and diluted:

                                
                                  

Loss before cumulative effect of adoption of a new accounting standard

   $ (0.14 )   $ (0.05 )   $ (0.96 )   $ (0.31 )

Cumulative effect of adoption of a new accounting standard, net of incomes taxes

     —         —         —         (0.27 )
    


 


 


 


Net loss – basic and diluted

   $ (0.14 )   $ (0.05 )   $ (0.96 )   $ (0.58 )
    


 


 


 


Weighted average shares:

                                
                                  

Basic and diluted

     9,024       9,048       9,021       9,042  
    


 


 


 


 

See accompanying notes to consolidated financial statements.

 

4


Table of Contents

Remedy Temp, Inc.

 

CONSOLIDATED STATEMENTS OF CASH FLOWS

(amounts in thousands)

 

(unaudited)

 

     Nine Months Ended

 
     June 27,
2004


   

June 29,

2003


 

Cash flows from operating activities:

                

Net loss

   $ (8,649 )   $ (5,218 )

Adjustments to reconcile net loss to net cash from operating activities:

                

Cumulative effect of adoption of a new accounting standard, net of income taxes

     —         2,421  

Depreciation and amortization

     4,515       4,052  

Provision for losses on accounts receivable

     720       1,142  

Restricted stock compensation expense

     609       935  

Changes in assets and liabilities:

                

Trading investments

     (469 )     (634 )

Accounts receivable

     4,897       5,092  

Prepaid expenses and other current assets

     (2,172 )     890  

Other assets

     940       333  

Accounts payable

     (3,059 )     3,035  

Accrued workers’ compensation

     4,245       4,458  

Accrued payroll, benefits and related costs

     (1,192 )     786  

Accrued licensees’ share of gross profit

     (94 )     (733 )

Other accrued expenses

     270       (887 )

Prepaid income taxes

     (314 )     (5,049 )
    


 


Net cash provided by operating activities

     247       10,623  
    


 


Cash flows from investing activities:

                

Purchase of fixed assets

     (1,321 )     (2,108 )

Purchase of available-for-sale investments

     (430 )     (23,959 )